银屑病治疗药物的研究进展

Abstract
Figure/Table
References (35)
Related Citation (15)

Download: PDF (0 KB) HTML (34 KB)
Export: BibTeX | EndNote (RIS)

Abstract Psoriasis is a chronic inflammatory skin disease which is caused by a variety of factors and easy to attack repeatedly.It has a long course and is difficult to cure.It can also induce various complications,including psoriatic arthritis,cardiovascular disease,metabolic syndrome and obesity,which seriously affect the quality of life of patients.In recent years,with in-depth research on the pathogenesis of psoriasis,many drugs that can effectively treat psoriasis have been developed,among which the research on psoriasis targeted therapeutic drugs has made great progress.This paper reviews the marketed compounds and clinical compounds of psoriasis.

Key words： Psoriasis Targeted drugs Therapy Research progress

Received: 08 June 2020

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WEI Yi-ying
	LI Shi-meng
	WEI Wen-guo
	ZHOU Hong-gang

Cite this article:

WEI Yi-ying,LI Shi-meng,WEI Wen-guo, et al. Research progress of therapeutic drugs for psoriasis[J]. 中国当代医药, 2021, 28(2): 30-36.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I2/30

[1]	Rendon A，Schakel K.Psoriasis Pathogenesis and Treatment[J].Int J Mol Sci，2019，20（6）：1475.
[8]	Lowes MA，Suárez-Farinas M，Krueger JG.Imm unology of psoriasis[J].Annu Rev Immunol，2014，32：227-255.
[14]	肖芳，郑成云，蒋卫东.NETs 在自身免疫性疾病发病机制中的作用研究进展[J].中国免疫学杂志，2017，33（5）：781-783，787.
[16]	李贝金，李潇，薛嘉睿，等.新冠肺炎炎症风暴的机制探讨及中医药的干预作用[J].中国实验方剂学杂志，2020，26（13）：32-38.
[23]	Visconti B，Paolino G，Carotti S，et al.Immunohistochemical expression of VDR is associated with reduced integrity of tight junction complex in psoriatic skin[J].J Eur Acad Dermatol Venereol，2015，29（10）：2038-2042.
[24]	Wang W，Shu GF，Lu KJ，et al.Flexible liposomal gel dualloaded with all-trans retinoic acid and betamethasone for enhanced therapeutic efficiency of psoriasis[J].J Nanobiotechnology，2020，18（1）：80.
[25]	Banerjee S，Biehl A，Gadina M，et al.JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases：Current and Future Prospects[J].Drugs，2017，77（5）：521-546.
[26]	Papp K，Gordon K，Thaci D，et al.Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis[J].N Engl J Med，2018，379（14）：1313-1321.
[27]	Li H，Zuo J，Tang W.Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases[J].Front Pharmacol，2018，9：1048.
[28]	朱愿超，孙雪林，胡欣.银屑病治疗靶向药物的研究进展[J].中国药房，2019，30（4）：542-547.
[29]	Siiskonen H，Harvima I.Mast Cells and Sensory Nerves Contribute to Neurogenic Inflammation and Pruritus in Chronic Skin Inflammation[J].Front Cell Neurosci，2019，13：422.
[30]	Jin J，Xue N，Liu Y，et al.A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models[J].Acta Pharm Sin B，2020，10（2）：276-288.
[31]	Maceyka M，Spiegel S.Sphingolipid metabolites in inflammatory disease[J].Nature，2014，510（7503）：58-67.
[32]	Mylonas A，Conrad C.Psoriasis：Classical vs.Paradoxical.The Yin-Yang of TNF and Type I Interferon[J].Front Immunol，2018，9：2746.
[33]	戴华拓，任韵清.生物制剂治疗银屑病的药物遗传学研究进展[J].中国麻风皮肤病杂志，2019，35（11）：696-700.
[34]	Hawkes JE，Yan BY，Chan TC，et al.Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis[J].J Immunol，2018，201（6）：1605-1613.
[35]	Hawkes JE，Chan TC，Krueger JG.Psoriasis pathogenesis and the development of novel targeted immune therapies[J].J Allergy Clin Immunol，2017，140（3）：645-653.
[2]	Mahil SK，Capon F，Barker JN.Update on psoriasis immunopathogenesis and targeted immunotherapy[J].Semin Immunopathol，2016，38（1）：11-27.
[3]	Lande R，Gregorio J，Facchinetti V，et al.Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide[J].Nature，2007，449（7162）：564-569.
[4]	Duvallet E，Semerano L，Assier E，et al.Interleukin-23：a key cytokine in inflammatory diseases[J].Ann Med，2011，43（7）：503-511.
[5]	Ganguly D，Haak S，Sisirak V，et al.The role of dendritic cells in autoimmunity[J].Nat Rev Immunol，2013，13（8）：566-577.
[6]	Arakawa A，Siewert K，Stohr J，et al.Melanocyte antigen triggers autoimmunity in human psoriasis[J].J Exp Med，2015，212（13）：2203-2212.
[7]	Di Cesare A，Di Meglio P，Nestle FO.The IL-23/Th17 axis in the immunopathogenesis of psoriasis[J].J Invest Dermatol，2009，129（6）：1339-1350.
[9]	Johnson-Huang LM，Suárez-Farinas M，Pierson KC，et al.A single intradermal injection of IFN-γ induces an inflammatory state in both non-lesional psoriatic and healthy skin[J].J Invest Dermatol，2012，132（4）：1177-1187.
[10]	Madonna S，Scarponi C，Sestito R，et al.The IFN-gammadependent suppressor of cytokine signaling 1 promoter activity is positively regulated by IFN regulatory factor-1 and Sp1 but repressed by growth factor independence-1b and Krüppel-like factor-4，and it is dysregulated in psoriatic keratinocytes[J].J Immunol，2010，185（4）：2467-2481.
[11]	Abdallah MA，Abdel-Hamid MF，Kotb AM，et al.Serum interferon -gamma is a psoriasis severity and prognostic marker[J].Cutis，2009，84（3）：163-168.
[12]	Deng Y，Chang C，Lu Q.The Inflammatory Response in Psoriasis：a Comprehensive Review[J].Clin Rev Allergy Immunol，2016，50（3）：377-389.
[13]	Shiga T，Sato K，Kataoka S，et al.TNF inhibitors directly target Th17 cells via attenuation of autonomous TNF/TNFR2 signalling in psoriasis[J].J Dermatol Sci，2015，77（1）：79-81.
[15]	Chousterman BG，Swirski FK，Weber GF.Cytokine storm and sepsis disease pathogenesis[J].Semin Immunopathol，2017，39（5）：517-528.
[17]	Mrowietz U，Kragballe K，Reich K，et al.Definition of treatment goals for moderate to severe psoriasis：a European consensus[J].Arch Dermatol Res，2011，303（1）：1-10.
[18]	Menter A.Psoriasis and psoriatic arthritis overview[J].Am J Manag Care，2016，22（8 Suppl）：s216-s224.
[19]	Chong M，Fonacier L.Treatment of Eczema：Corticosteroids and Beyond[J].Clin Rev Allergy Immunol，2016，51（3）：249-262.
[20]	Smith CH，Barker JN.Psoriasis and its management[J].BMJ，2006，333（7564）：380-384.
[21]	Sevilla LM，Pé rez P.Glucocorticoids and Glucocorticoid-Induced-Leucine-Zipper（GILZ）in Psoriasis[J].Front Immunol，2019，10：2220.
[22]	Li J，Sun L，Sun J，et al.Pooling analysis regarding the impact of human vitamin D receptor variants on the odds of psoriasis[J].BMC Med Genet，2019，20（1）：161.